摘要1 型糖尿病是一类由自身免疫反应介导, 致使胰岛β 细胞损伤的慢性疾病.
传统的治疗方法并不能治愈该疾病. 针对1 型糖尿病发病机制, 抑制自身免疫, 恢复免疫平衡 …

Umbilical cord blood contains several types of stem cells that are of interest to a wide range
of disciplines in regenerative medicine. The translational potential to the clinical applications …

Type 1 diabetes (T1D) is an autoimmune disease caused by an autoimmune destruction of
pancreatic islet insulin-producing cells. Autoimmunity and shortage of insulin-producing …

The prevalence of type 2 diabetes (T2D) is increasing worldwide, highlighting the need for a
better understanding of the pathogenesis of the disease and the development of innovative …

In recent years, human umbilical cord blood has emerged as a rich source of stem, stromal
and immune cells for cell-based therapy. Among the stem cells from umbilical cord blood …

OBJECTIVE: The physical, emotional, and economic costs of type 1 diabetes (T1D) mandate
continued efforts to develop effective strategies to prevent or reverse the disease. Herein, we …

Background Type 2 diabetes mellitus (T2DM) is a serious threat to human health and
remains incurable. Insulin deficiency seems to be attributed to the progressive failure of …

Background Inability to control autoimmunity is the primary barrier to developing a cure for
type 1 diabetes (T1D). Evidence that human cord blood-derived multipotent stem cells (CB …

摘要背景: 1 型糖尿病是一种以T 细胞介导的胰岛β 细胞损伤为特征的自身免疫性疾病,
实验拟针对其免疫机制进行干预, 并用干细胞修复受损的胰岛β 细胞, 探索治疗1 …

The pathology of type 1 diabetes mellitus (T1D) involves the autoimmune destruction or
malfunction of pancreatic β cells, leading to a lack of insulin. The absence of insulin is life …